Cardiovascular Systems Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 725

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $851M

Cardiovascular Systems General Information

Description

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Contact Information

Website
www.csi360.com
Formerly Known As
Shturman Cardiology Systems
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
Corporate Office
  • 1225 Old Highway 8 Northwest
  • Saint Paul, MN 55112
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiovascular Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 27-Apr-2023 $851M 00000 00000 Completed Generating Revenue
12. Secondary Transaction - Open Market 31-Dec-2011 00000 Completed Generating Revenue
11. Secondary Transaction - Open Market 31-Dec-2010 00000 Completed Generating Revenue
10. Reverse Merger 25-Feb-2009 00000 Completed Generating Revenue
9. IPO 06-Nov-2008 000.00 Cancelled Generating Revenue
8. Later Stage VC (Series B) 19-Dec-2007 000.00 00000 Completed Generating Revenue
7. Later Stage VC 21-Sep-2007 000.00 00000 Completed Generating Revenue
6. Later Stage VC 09-Oct-2006 000 00000 Completed Generating Revenue
5. Later Stage VC 31-Jul-2006 $25M $152M Completed Generating Revenue
4. Later Stage VC (Series D) 29-Aug-2005 $62.5M $126M 00000 Completed Generating Revenue
To view Cardiovascular Systems’s complete valuation and funding history, request access »

Cardiovascular Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 4,000,000 $0.010000 8% $1.25 $1.25 1x $1.25 3.49%
Series A 13,140,000 $0.010000 8% $1 $1 1x $1 11.4%
To view Cardiovascular Systems’s complete cap table history, request access »

Cardiovascular Systems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery disea
Surgical Devices
Saint Paul, MN
725 As of 2022
00000
00000 0000-00-00
000000&0 00000

000000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nos
00000000 0000000
Mason, OH
0000 As of 0000
00000
000000000 00 00000

000000

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
00000 0000000 000 00
Redwood City, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cardiovascular Systems Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Atricure Formerly VC-backed Mason, OH 0000 00000 000000000 00 00000
Avinger Formerly VC-backed Redwood City, CA 00 00000 000000000 00000
Angiodynamics Private Debt Financed New York, NY 000 00000 000000000 00 00000
Teleflex Corporation Wayne, PA 00000 00.000 000000000 00.000
Jarvik Heart Corporation New York, NY
You’re viewing 5 of 31 competitors. Get the full list »

Cardiovascular Systems Executive Team (17)

Name Title Board Seat Contact Info
Jeffrey Points Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Stephen Rempe Chief Human Resources Officer
You’re viewing 2 of 17 executive team members. Get the full list »

Cardiovascular Systems Board Members (14)

Name Representing Role Since
Stephen Stenbeck Cardiovascular Systems Board Member 000 0000
William Cohn Cardiovascular Systems Board Member 000 0000
You’re viewing 2 of 14 board members. Get the full list »

Cardiovascular Systems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardiovascular Systems Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Easton Capital Investment Group Venture Capital Minority 000 0000 000000 0
GSK Corporation Minority 000 0000 000000 0
HealthCare Ventures Venture Capital Minority 000 0000 000000 0
JPB Partners PE/Buyout Minority 000 0000 000000 0
Lumira Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Cardiovascular Systems Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CarePICS 08-Apr-2021 0000000000 Other Healthcare Services
CarePICS 08-Apr-2021 000000000 Other Healthcare Services 00000 000
WavePoint (Peripheral Support Catheters) 22-Mar-2021 000000000 00.000 Buildings and Property 00000 000
Gardia Medical (WIRION Embolic Protection System and Related Assets) 05-Aug-2019 000000000 000.00 Buildings and Property 00000 000
Aerolase 31-Jul-2018 Corporate Therapeutic Devices 00000 000
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Cardiovascular Systems FAQs

  • When was Cardiovascular Systems founded?

    Cardiovascular Systems was founded in 1989.

  • Where is Cardiovascular Systems headquartered?

    Cardiovascular Systems is headquartered in Saint Paul, MN.

  • What is the size of Cardiovascular Systems?

    Cardiovascular Systems has 725 total employees.

  • What industry is Cardiovascular Systems in?

    Cardiovascular Systems’s primary industry is Surgical Devices.

  • Is Cardiovascular Systems a private or public company?

    Cardiovascular Systems is a Private company.

  • What is the current valuation of Cardiovascular Systems?

    The current valuation of Cardiovascular Systems is 00000.

  • What is Cardiovascular Systems’s current revenue?

    The current revenue for Cardiovascular Systems is 000000.

  • How much funding has Cardiovascular Systems raised over time?

    Cardiovascular Systems has raised $183M.

  • Who are Cardiovascular Systems’s investors?

    Easton Capital Investment Group, GSK, HealthCare Ventures, JPB Partners, and Lumira Ventures are 5 of 16 investors who have invested in Cardiovascular Systems.

  • Who are Cardiovascular Systems’s competitors?

    Atricure, Avinger, Angiodynamics, Teleflex, and Jarvik Heart are some of the 31 competitors of Cardiovascular Systems.

  • When was Cardiovascular Systems acquired?

    Cardiovascular Systems was acquired on 27-Apr-2023.

  • Who acquired Cardiovascular Systems?

    Cardiovascular Systems was acquired by Abbott.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »